Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study-Reference-Cited by-同舟云学术

Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study

Published:2018 Issue:6 Volume:65 Page:639-643
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Murakami Mariko¹,Nagai Yoshio¹,Tenjin Ayumi¹,Tanaka Yasushi¹

Affiliation:

1. Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/65/6/65_EJ17-0380/_pdf

Reference17 articles.

1. 1 Duffy JP, Eibl G, Reber HA, Hines OJ (2003) Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer. Mol Cancer 2: 12.

2. 2 Kato K, Kamada H, Fujimori T, Aritomo Y, Ono M, et al. (2012) Molecular biologic approach to the diagnosis of pancreatic carcinoma using specimens obtained by EUS-Guided fine needle aspiration. Gastroenterol Res Pract 2012: 243524.

3. 3 Wang Z, Tian YP (2014) Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma. Mol Clin Oncol 2: 265–268.

4. 4 Goonetilleke KS, Siriwardena AK (2007) Systematic review of carbohydrate antigen (CA19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 33: 266–270.

5. 5 Narimatsu H, Iwasaki H, Nakayama F, Ikehara Y, Kudo T, et al. (1998) Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients. Cancer Res 58: 512–518.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organ-specific variations in tumor marker dynamics in postoperative pancreatic cancer recurrence: Trends in lung and liver recurrence highlighting biological heterogeneity;Surgical Oncology;2024-08

2. Diagnostic impact of postoperative CA19-9 dynamics on pancreatic cancer recurrence: a single-institution retrospective study;Updates in Surgery;2024-02-13

3. Biological risk based on preoperative serum CA19‐9 and histological grade predicts prognosis and improves accuracy of classification in patients with pancreatic ductal adenocarcinoma;Cancer Reports;2023-10-12

4. Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test;Cancers;2023-05-30

5. Obesity, diabetes mellitus, and pancreatic carcinogenesis: Correlations, prevention, and diagnostic implications;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-01